GCCL Expands Laboratory 2.5 Times with Office Relocation
GCCL, a clinical trial specimen analysis institution, announced on the 27th that it has relocated its office from the existing GC Green Cross Mokam Campus laboratory and office to the newly established Guseong Campus.
GCCL explained that it has integrated the previously separately operated laboratories?the 1st Laboratory (Bio Analysis) and the 2nd Laboratory (General Automation)?and expanded the scale by 2.5 times compared to before. Through this, they plan to improve the efficiency and convenience of the work process, from specimen reception, preprocessing, analysis, to specimen storage.
The laboratory space has also been expanded. The total of three teams?Bio Analysis (BA) Teams 1 and 2, and the Clinical Lab (CL) Team?will be expanded to four teams this year with the establishment of a Translational Research (TR) Team. Based on this, they intend to broaden their expertise not only in immunogenicity analysis of anti-drug antibodies (ADA) related to oncology, including synthetic drug clinical trials and advanced biopharmaceutical clinical trials, but also in central nervous system (CNS) disease analysis services.
Hot Picks Today
Dramatic Agreement Reached on Eve of Samsung Electronics General Strike... Minister Kim Young-hoon: "Showcased Korea's Strength in Dialogue" (Update)
- "It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Yang Song-hyun, CEO of GCCL, stated, “This laboratory expansion will be the starting point for advancing into a central lab with global-level competitiveness,” and added, “We will also concretize plans to expand beyond being Korea’s representative central lab to becoming a global lab.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
